Magnetic Biosensor Competitive Assay for Small Molecule Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current biosensing techniques for detecting small molecule analytes are complex and require additional steps like washing, limiting their suitability for high sensitivity and point-of-care applications.
Innovation Solution
The use of magnetic biosensors with nanoparticle tags and a competitive assay scheme, where a capture probe immobilized on the sensor competes with analytes for detection probes, allowing for concentration-dependent detection of small molecules less than 1000 Daltons without the need for washing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current high sensitivity immunoassay techniques use a competitive assay reaction scheme with washing steps, then sensitivity is improved, but device complexity and ease of operation worsen due to additional washing steps
Solution Approach 1:
The invention extracts and eliminates the washing step from the traditional competitive immunoassay protocol. By using magnetic biosensors that detect binding events in real-time without requiring removal of unbound components, the method achieves high sensitivity while simplifying the assay procedure to a single-step addition of sample and detection probes.
Solution Approach 2:
The invention replaces the mechanical washing process with a magnetic detection system. Instead of physically removing unbound components through washing, the magnetic biosensor selectively detects bound magnetic tags while ignoring unbound ones, achieving the same separation function through magnetic field interaction rather than mechanical fluid manipulation.
2Measurement precision
If washing steps are added to remove background signal, then measurement precision is improved, but ease of operation and time efficiency worsen
Solution Approach 1:
The magnetic detection system replaces mechanical washing with magnetic field-based detection. The biosensor distinguishes between bound and unbound magnetic tags through their different magnetic environments, achieving background signal rejection without physical washing steps, thereby simplifying operation while maintaining precision.
Solution Approach 2:
The magnetic tag serves as an intermediary that enables detection without washing. By attaching magnetic particles to detection probes, the system creates a detectable signal that can be measured in the presence of unbound components, eliminating the need for washing while maintaining signal-to-noise ratio.
3Measurement precision
If magnetic tags are used with capture probes immobilized on sensor, then detection sensitivity for small molecules is improved, but device complexity increases due to functionalization requirements
Solution Approach 1:
The magnetic biosensor platform uses universal capture probe functionalization that can detect multiple different small molecule analytes by simply changing the detection probes, not the sensor surface chemistry. This multi-functional approach reduces the complexity of sensor fabrication while maintaining high detection sensitivity across different analytes.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables rapid, precise detection of low nanomolar concentrations of small molecules, such as THC in saliva, with improved sensitivity and simplicity, suitable for point-of-care devices, and is applicable to various small molecule analytes including THC, morphine, and other drugs.
Implementation Method 1
measuring binding of the magnetic tags to the magnetic biosensor
Data Source
AI summary
Small molecule analytes (less than 1000 Daltons) in a fluid sample are detected using a competitive assay in a magnetic biosensor. The fluid sample is added to a biosensor detection chamber together with detection probes and magnetic tags which bind to the detection probes. The magnetic biosensor is functionalized with a capture probe that shares an epitope with the analytes, and the detection probe is capable of binding the epitope shared by the analytes and the capture probe, so that the presence of the analyte prevents detection probes (and magnetic tags) from binding to the biosensor. By measuring the binding of the magnetic tags to the magnetic biosensor, an amount of analytes in the solution is determined.